Hemics wins Investors Forum

At the Dutch Life Sciences conference, Petra van den Elsen MD, PhD, MBA, CEO of Hemics B.V. pitched their business plan to a group of life science investors. Among the nine candidates, Hemics was chosen by the jury as the winner of the Investors Forum 2017. Hemics is a medical device company, founded as a spin-out of Royal Philips Electronics, and active in the field of Rheumatoid Arthritis (RA). Their devices are based on the patented Optical Inflammation Detection technology, a non-invasive, fast and objective method that supports rheumatologists in the quantification of inflammation, a key parameter in the treatment of patients with RA.